[In Press] The impact of combined oral contraceptives on ocular tissues: a review of ocular effects |
| |
Authors: | Marilita M. Moschos Eirini Nitoda |
| |
Affiliation: | 1Department of Ophthalmology, Medical School, National &Kapodistrian University of Athens, Greece6, Ikarias street, Ekali 14578, Athens, Greece2Department of Ophthalmology, Medical School, National &Kapodistrian University of Athens, Greece |
| |
Abstract: | This paper was aimed to review the action and adverse effects of Combined Oral Contraceptives on ocular tissues. Over 100 million women around the world use common contraceptive methods, including intrauterine devices, combined estrogen and progestin oral contraceptives (COCs), as well as progestin only preparations (oral contraceptives, implants or injections). COCs are widely used for contraception, but they are also indicated in menorrhagia, endometriosis, acne and hirsutism, fibroid uterus and premenstrual syndrome. However, they have been associated with high rates of cardiovascular events, venous thromboembolic disease, ischemic strokes and breast cancer. The incidence of COCs-related ocular complications was estimated to be 1 in 230,000, including dry eye symptoms, corneal edema, lens opacities and retinal neuro-ophthalmologic or vascular complications. We may infer that the serious ocular complications of COCs can be prevented by eliminating the estrogen dosage and choosing third-generation progestins. In any case, doctors should take into consideration the systemic and ocular history of the patients before selecting any method of contraception. |
| |
Keywords: | adverse effects ocular complications oral contraceptives |
|
| 点击此处可从《国际眼科》浏览原始摘要信息 |
|
点击此处可从《国际眼科》下载全文 |
|